Library of services

• ACE (Alu Ins/Del) angiotensin-converting enzyme gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to high sporting achievements

• ACTN3 (R577X)

  • DNA diagnostics for a predisposition to high sporting achievements

• ADIPOQ (-11391 G/A) adiponectin

  • DNA diagnostics for a predisposition to metabolic syndrome

• ADIPOQ (+276G > T) adiponectin

  • DNA diagnostics for a predisposition to type 2 diabetes

  • DNA diagnostics for a predisposition to metabolic syndrome

• AGTR1 (А1166С) angiotensin II type 1 receptor gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

• AHR (A/G rs4410790) aryl hydrocarbon receptor gene

  • DNA diagnostics of caffeine metabolism efficiency

• AMPD1 (C34T) adenosine monophosphate deaminase 1 gene

  • DNA diagnostics for a predisposition to high sporting achievements

• APOE (Cys112Arg; Arg158Cys) apolipoprotein E gen

  • DNA diagnostics for a predisposition to pregnancy loss

  • Testing of genes that determine effective weight loss as a result of physical exercise

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to hypercholesterolemia

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• BDKRB2 (I/D) bradykinin β2 receptor gene

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to high sporting achievements

• COL1A1 (G441T) collagen alpha-1(I) chain

  • Genetic testing for a predisposition to osteoporosis

  • Genetic testing for a predisposition to the ruptures and sprains of ligaments and tendons

• COL1A2 (A18162G) collagen alpha-2(I) chain

  • Genetic testing for a predisposition to osteoporosis

• COL5A1 (C267T) collagen, type V, alpha-1 gene

  • Genetic testing for a predisposition to the ruptures and sprains of ligaments and tendons

• COMT (32519G>A) catechol-O-methyltransferase gene

  • DNA diagnostics of a person’s psycho-emotional status

• COMT (472G>A) catechol-O-methyltransferase gene

  • DNA diagnostics of a person’s psycho-emotional status

• CYBA (C242T) cytochrome b gene

  • DNA diagnostics for a predisposition to pregnancy loss

• CYP1A2 (C/T rs2472297) cytochrome P450 family 1 subfamily A member 2

  • DNA diagnostics of caffeine metabolism efficiency

• DARPP32 (12195G>A) the gene regulating the efficacy of dopaminergic neurotransmission

  • DNA diagnostics of a person’s psycho-emotional status

• DARPP32 (12763C>Т) the gene regulating the efficacy of dopaminergic neurotransmission

  • DNA diagnostics of a person’s psycho-emotional status

• DBH (4031T>C) dopamine beta-hydroxylase gene

  • DNA diagnostics of a person’s psycho-emotional status

• DQ (A1)

  • DNA diagnostics for a predisposition to celiac disease (gluten intolerance)

• DQ (B1)

  • DNA diagnostics for a predisposition to celiac disease (gluten intolerance)

• DRD2 (939С/Т) dopamine receptor D2 gene

  • DNA diagnostics of a person’s psycho-emotional status

• DRD2 (C/T rs1800497) dopamine receptor D2 gene

  • DNA diagnostics of a person’s psycho-emotional status

• eNOS (4a/4b) endothelial nitric oxide synthase gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • DNA diagnostics for a predisposition to high sporting achievements

• eNOS (G894T) endothelial nitric oxide synthase gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics of drug therapy effectiveness

• EPO (G3876T) erythropoietin receptor gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to high sporting achievements

• F1 (Thr312Ala) coagulation factor I gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• F11 (C/T rs2289252) coagulation factor XI gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• F11 (T/C rs2036914) coagulation factor XI gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• F13 (Val34Leu) coagulation factor XIII gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• F2 (G20210А) coagulation factor II gene — prothrombin

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • DNA diagnostics for thrombosis risk in women taking hormonal contraceptives

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• F5 (Arg506Gln) coagulation factor V gene. Leiden mutation

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • DNA diagnostics for thrombosis risk in women taking hormonal contraceptives

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• F7 (G10976A) coagulation factor VII gene — proconvertin

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

• FGG (C10034T) fibrinogen gamma chain

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• FTO (c.IVS1 A>T) alpha-ketoglutarate-dependent dioxygenase

  • Testing of genes that determine effective weight loss as a result of physical exercise

  • DNA diagnostics for a predisposition to metabolic syndrome

• GABRA2 (82464A>G) gamma-aminobutyric acid type A receptor subunit alpha2

  • DNA diagnostics of a person’s psycho-emotional status

• GAD1 (1922G>A) glutamate carboxylase gene

  • DNA diagnostics of a person’s psycho-emotional status

• GAD1 (5276G>A) glutamate carboxylase gene

  • DNA diagnostics of a person’s psycho-emotional status

• GNB3 (С825Т) G protein subunit beta 3

  • DNA diagnostics for a predisposition to type 2 diabetes

  • DNA diagnostics for a predisposition to metabolic syndrome

• GP1BA (-5T>С) glycoprotein Ib platelet subunit

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

• Gp6 (A/G rs1613662) glycoprotein VI

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

• HIF1A (C1772T) hypoxia-inducible factor

  • DNA diagnostics for a predisposition to pregnancy loss

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to high sporting achievements

• HTR2A (833C/T) serotonin-2A receptor gene

  • DNA diagnostics of a person’s psycho-emotional status

• IL1B (11055 T>C) interleukin 1 beta

  • DNA diagnostics of a person’s psycho-emotional status

• IL1B (4490 G>A) interleukin 1 beta

  • DNA diagnostics of a person’s psycho-emotional status

• ITGA2 (C807T) integrin subunit alpha 2

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

• ITGB3 (T1565C) integrin beta 3 binding protein

  • DNA diagnostics for a predisposition to pregnancy loss

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

• KCNJ (11Glu23Lys) potassium channel regulator

  • DNA diagnostics for a predisposition to type 2 diabetes

• LCT (T-13910C) lactase enzyme

  • Genetic testing for a predisposition to osteoporosis

• LDLR (7TA,8TA,10TA,11TA) low density lipoprotein receptor

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to hypercholesterolemia

• LEP (G(-2548)A) leptin

  • DNA diagnostics for a predisposition to metabolic syndrome

• MAO A (30-bpVNTR) monoamine oxidase A

  • DNA diagnostics of a person’s psycho-emotional status

• MB (A79G) myoglobin gene

  • DNA diagnostics for a predisposition to high sporting achievements

• MC4R (T>C) melanocortin 4 receptor

  • DNA diagnostics for a predisposition to metabolic syndrome

• MMP3 (Glu45Lys) matrix metallopeptidase 3

  • Genetic testing for a predisposition to the ruptures and sprains of ligaments and tendons

• MTHFR (А1298С) methylenetetrahydrofolate reductase

  • DNA diagnostics for a predisposition to pregnancy loss

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics of drug therapy effectiveness

• MTHFR (С677Т) methylenetetrahydrofolate reductase

  • DNA diagnostics for a predisposition to pregnancy loss

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics of drug therapy effectiveness

• MTR (А2756G) methionine synthase gene

  • DNA diagnostics for a predisposition to pregnancy loss

• PAI-1 (4G/5G) plasminogen activator inhibitor-1

  • DNA diagnostics for a predisposition to pregnancy loss

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to high sporting achievements

• PPARA (G2528C) peroxisome proliferator-activated receptor delta gene

  • DNA diagnostics for a predisposition to type 2 diabetes

  • DNA diagnostics for a predisposition to hypercholesterolemia

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• PPARD (+294T/C) peroxisome proliferator-activated receptor delta gene

  • DNA diagnostics for a predisposition to pregnancy loss

  • Testing of genes that determine sports nutrition effectiveness

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • DNA diagnostics for a predisposition to hypercholesterolemia

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• PPARG (Pro12Ala) peroxisome proliferator-activated receptor gamma

  • DNA diagnostics for a predisposition to type 2 diabetes

  • Testing of genes that determine sports nutrition effectiveness

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• PPARGC1A (G1564A) nuclear receptor coactivator PPAR

  • DNA diagnostics for a predisposition to type 2 diabetes

  • DNA diagnostics for a predisposition to pregnancy loss

  • Testing of genes that determine sports nutrition effectiveness

  • DNA diagnostics for a predisposition to thrombosis and hypertensive crises

  • DNA diagnostics for a predisposition to hypercholesterolemia

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• TCF7L2 (C-41435T) transcription factor 7

  • DNA diagnostics for a predisposition to type 2 diabetes

• UCP2 (Ala55Val) uncoupling protein

  • DNA diagnostics for a predisposition to type 2 diabetes

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• UCP3 (-55C/T) uncoupling protein 3

  • DNA diagnostics for a predisposition to hypercholesterolemia

  • DNA diagnostics for a predisposition to metabolic syndrome

  • DNA diagnostics for a predisposition to high sporting achievements

• VDR (ApaI) vitamin D receptor

  • Genetic testing for a predisposition to osteoporosis

• VDR (BsmI) vitamin D receptor

  • Genetic testing for a predisposition to osteoporosis

• VDR (Cdx2) vitamin D receptor

  • Genetic testing for a predisposition to osteoporosis

• VDR (TaqI) vitamin D receptor

  • Genetic testing for a predisposition to osteoporosis

• VEGF (G-634C) vascular endothelial growth factor A

  • DNA diagnostics for a predisposition to pregnancy loss

  • Quantitative assessment of the genetic risk of cardiovascular diseases of various nosologies

  • DNA diagnostics for a predisposition to high sporting achievements